Imperial Capital downgraded Stericycle (NASDAQ: SRCL) from In-Line to Underperform with a price target of $93.50 (from $100.00).

Analyst Scott Levine commented, "We are lowering our rating on SRCL shares to Underperform from In-Line, and are lowering our one-year price target to $93.50 from $100. Our price target is 12% below the recent share price. Although we expect SRCL to remain a leader within the medical waste industry, we await a reacceleration in earnings growth, improvement in its visibility, or a more attractive valuation, before becoming more positive."

For an analyst ratings summary and ratings history on Stericycle click here. For more ratings news on Stericycle click here.

Shares of Stericycle closed at $105.93 yesterday.